100% Quality Guarantee
PhD-Level Technical Support
Anti-ICAM1 bersanlimab biosimilar mAb HDBS0036
Key Features

Bersanlimab Biosimilar (ICAM1) Antibody (HDBS0036)

SKU HDBS0036
Antibody Type Biosimilar Reference Antibody
Applications IHC
Applications FC
Applications Drug Development
Applications Pharmacokinetics
Disease Area Cancer
Protein ICAM1
Reactivity Human
Host Species Humanized
Isotype IgG1
€431

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheet

Bersanlimab Biosimilar (ICAM1) Antibody (HDBS0036)

The ICAM1 (Bersanlimab Biosimilar) Monoclonal Antibody (HDBS0036) is a cutting-edge tool for researchers studying ICAM1, a cell adhesion molecule involved in immune and inflammatory processes. This monoclonal antibody, produced through biosimilar technology, offers high specificity and sensitivity in detecting and quantifying ICAM1 expression in various sample types, including human tissues and cell lines.ICAM1, also known as intercellular adhesion molecule-1, plays a crucial role in immune responses by facilitating leukocyte adhesion and migration to sites of inflammation. Dysregulation of ICAM1 has been implicated in various diseases, including cardiovascular disorders, autoimmune conditions, and cancer.

The Anti-ICAM1 Monoclonal Antibody provides a valuable tool for investigating the role of ICAM1 in these pathologies and developing targeted therapies.With its proven efficacy in immunohistochemistry and flow cytometry applications, this antibody allows for precise localization and quantification of ICAM1 expression in tissue samples and cell populations. Researchers in the fields of immunology, oncology, and vascular biology will benefit from the accurate and reliable results obtained using the Anti-ICAM1 (Bersanlimab Biosimilar) Monoclonal Antibody (HDBS0036).

View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose